Publications

6434 items matching your search terms.

Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein

Brummer, T.;Martin, P.;Herzog, S.;Misawa, Y.;Daly, R. J.;Reth, M. :

ONCOGENE 25 (47) :6262-76, 2006

The urokinase/PAI-2 complex: a new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein

Croucher, D.;Saunders, D. N.;Ranson, M. :

JOURNAL OF BIOLOGICAL CHEMISTRY 281 (15) :10206-13, 2006

Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice

Wultsch, T.;Painsipp, E.;Donner, S.;Sperk, G.;Herzog, H.;Peskar, B. A.;Holzer, P. :

BEHAVIOURAL BRAIN RESEARCH 168 (2) :255-60, 2006

Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA

Severi, G.;Hayes, V. M.;Neufing, P.;Padilla, E. J.;Tilley, W. D.;Eggleton, S. A.;Morris, H. A.;English, D. R.;Southey, M. C.;Hopper, J. L.;Sutherland, R. L.;Boyle, P.;Giles, G. G. :

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 15 (6) :1142-7, 2006

A new role for CCR5 in innate immunity--binding to bacterial heat shock protein 70

Mackay, C. R.;Sallusto, F. :

EUROPEAN JOURNAL OF IMMUNOLOGY 36 (9) :2293-5, 2006

Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells

Rentero, C.;Evans, R.;Wood, P.;Tebar, F.;Vila de Muga, S.;Cubells, L.;de Diego, I.;Hayes, T. E.;Hughes, W. E.;Pol, A.;Rye, K. A.;Enrich, C.;Grewal, T. :

CELLULAR SIGNALLING 18 (7) :1006-16, 2006

Functional Characterization of PIK3CA as a breast cancer oncogene

Bennett, H. L.;Daly, R. J. :

Breast Cancer Online (BCO) www.bco.org :Published, 2006

Socs2 and elf5 mediate prolactin-induced mammary gland development

Harris, J.;Stanford, P. M.;Sutherland, K.;Oakes, S. R.;Naylor, M. J.;Robertson, F. G.;Blazek, K. D.;Kazlauskas, M.;Hilton, H. N.;Wittlin, S.;Alexander, W. S.;Lindeman, G. J.;Visvader, J. E.;Ormandy, C. J. :

MOLECULAR ENDOCRINOLOGY 20 (5) :1177-87, 2006

Beta3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)

Wang, C. Y.;Nguyen, N. D.;Morrison, N. A.;Eisman, J. A.;Center, J. R.;Nguyen, T. V. :

BMC Medical Genetics 7 :57, 2006

The pathology of multiple sclerosis: a paradigm shift

Barnett, M. H.;Sutton, I. :

CURRENT OPINION IN NEUROLOGY 19 (3) :242-7, 2006

Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats

Ye, J. M.;Dzamko, N.;Hoy, A. J.;Iglesias, M. A.;Kemp, B.;Kraegen, E. :

DIABETES 55 (10) :2797-804, 2006

Hyperimmune goat serum (Aimspro): hope or hype?

Sutton, I.;Kermode, A. G. :

JOURNAL OF CLINICAL NEUROSCIENCE 13 (10) :1037-8, 2006

The subcellular fractionation properties and function of insulin receptor substrate-1 (IRS-1) are independent of cytoskeletal integrity

Thomas, E. C.;Zhe, Y.;Molero, J. C.;Schmitz-Peiffer, C.;Ramm, G.;James, D. E.;Whitehead, J. P. :

Int J Biochem Cell Biol 38 (10) :1686-99, 2006

Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas

Sutherland, A. P.;Mackay, F.;Mackay, C. R. :

PHARMACOLOGY & THERAPEUTICS 112 (3) :774-86, 2006

BAFF, APRIL and human B cell disorders

Tangye, S. G.;Bryant, V. L.;Cuss, A. K.;Good, K. L. :

SEMINARS IN IMMUNOLOGY 18 (5) :305-17, 2006

Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease

Boyman, O.;Surh, C. D.;Sprent, J. :

EXPERT OPINION ON BIOLOGICAL THERAPY 6 (12) :1323-31, 2006